Page last updated: 2024-09-04

moxifloxacin and Acute Disease

moxifloxacin has been researched along with Acute Disease in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.77)	18.2507
2000's	27 (50.94)	29.6817
2010's	20 (37.74)	24.3611
2020's	4 (7.55)	2.80

Authors

Authors	Studies
Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J	1
Honkila, M; Ikäheimo, I; Kontiokari, T; Koskela, U; Kristo, A; Mattila, ML; Paalanne, N; Pokka, T; Renko, M; Sarlin, S; Tapiainen, T; Uhari, M; Valtonen, R	1
Ansari, Y; Capewell, N; Hui, BTK; Liu, X	1
Deans, KJ; Minneci, PC	1
Aarnio, M; Grönroos, J; Haijanen, J; Hurme, S; Ilves, I; Laukkarinen, J; Löyttyniemi, E; Marttila, H; Mattila, A; Meriläinen, S; Nordström, P; Paajanen, H; Pinta, T; Rantanen, T; Rautio, T; Rintala, J; Salminen, P; Sävelä, EL; Savolainen, H; Sippola, S; Sippola, T; Tammilehto, V	1
Broens, A; Collignon, N	1
Augustinus, A; Hondeghem, K; Kreps, EO; Leroy, BP; Schauwvlieghe, PP; Sys, C; Van de Veire, S	1
Fanlo, P; Heras-Mulero, H; Plaza-Ramos, P; Zubicoa, A	1
Detry, O; Haumann, A; Meunier, P; Meurisse, M; Ongaro, S	1
Bond, WI; Brown, JA; Hahn, JM; Kishore, K; Satar, JM	1
Alves, M; Assis Filho, HL; Cardoso da Silva, I; Cavalcanti Lira, RP; Dias Freire, LM; Ferreira, BG; Leite Arieta, CE; Martini, AAF; Melega, MV; Pedreira Chaves, FR; Reis, RD	1
Arvis, P; Desrosiers, M; Heldner, S; Mösges, R	1
Belfort, R; Campos, MS; Nascimento, HM; Sousa, JM	1
Balkman, JD; Ball, PA; Bauer, DF; Lollis, SS; Whitson, WJ	1
Bui, CL; Calingaert, B; Castellsague, J; Holick, CN; Kaye, JA; McQuay, LJ; Perez-Gutthann, S; Quinlan, S; Riera-Guardia, N; Rothman, KJ; Saltus, CW; Suzart, K; Wahl, PM; Wallander, MA	1
Edzhe, MA; Hon, EM; Korostelev, SA; Miroshnichenko, NA; Ovchinnikov, AY	1
Gregory, DG	1
Huber, W; Kamereck, K; Prinz, C; Schmid, RM; Voland, P; Weber, A; Weidenbach, H; Winkle, P	1
Adelglass, J; Benson, A; Johnson, P; Keating, K; Pertel, P; Rankin, B; Sterling, R	1
Chamorro Mohedano, J; Díaz Souza, P; Puerto Alonso, JL; Rojas Martín, E	1
Heystek, M; Ross, JD	1
Becker, J; Chatzikyrkou, C; Clajus, C; Hafer, C; Hamwi, I; Kielstein, JT	1
Hooper, CY; Khan, A; Lightman, SL; Pacheco, P; Tam, PM; Taylor, SR	1
Anzueto, A; Ewig, S; Heldner, S; Legnani, D; Miravitlles, M; Stauch, K	1
Juurlink, DN; Mamdani, MM; Manno, M; Paterson, JM	1
Macklin-Doherty, A; Wilson, R	1
Chuchalin, A; Dokic, D; Marschall, HP; Petri, T; Tokić, M; Zakharova, M	1
Avila, S; González, A; Lancho, A; López-Rosés, L; Santos, E; Soto, S; Urraca, B	1
Egorov, VI; Kozarenko, AV	1
Casali, L; Curti, E; Grassi, C; Lazzaro, C; Schito, G; Tellarini, M	1
Arvis, P; Klossek, JM; Leberre, MA; Nikolaidis, P; Siegert, R	1
Miravitlles, M; Torres, A	1
Allegra, L; Huchon, G; Izquierdo, JL; Jones, P; Sagnier, PP; Schaberg, T; Wilson, R	1
Choudhri, S; Cihon, C; Herrington, J; Johnson, P	1
Bringas Calvo, R; Iglesias Cortiñas, D	1
Ferguson, BJ; Guzzetta, RV; Hadley, JA; Spector, SL	1
Wilson, R	1
Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K	1
Argirov, M; Fischereder, M; Ricken, G; Zecher, D	1
Friedman, HS; Keating, KN; Perfetto, EM	1
Anzueto, A; Choudhri, S; Haverstock, D; Kureishi, A; Niederman, MS; Perroncel, R; Sethi, S	1
Blair, C; Kirtsreesakul, V; Luxameechanporn, T; Naclerio, RM; Thompson, K	1
Deramo, VA; Fastenberg, DM; Lai, JC; Udell, IJ	1
Chuchueva, NG; Ivanchenko, OA; Lopatin, AS	1
Dimopoulos, G; Falagas, ME; Giannopoulou, KP; Grammatikos, AP; Karageorgopoulos, DE	1
Burke, T; Church, D; Haverstock, D; Heyd, A; Huck, W; Mariano, H; Orchard, D; Villanueva, C	1
Ballin, I; Bassaris, HP; Deppermann, KM; Kubin, R; Leophonte, P; Schreurs, AJ; Sommerauer, B; Torres, A; Wilson, R	1
Aneiro, L; Chodosh, S; Church, D; DeAbate, CA; Haverstock, D	1
Bagger-Sjöbäck, D; Gehanno, P; Hampel, B; Ibanez, JM; Nikolaidis, P; Siegert, R; Sommerauer, B	1
Church, D; DeAbate, CA; Heyd, A; Mathew, CP; Warner, JH	1
Flores, SM; Heyd, A; Rakkar, S; Roberts, K; Towe, BF; Warner, J	1
Cobos, A; Kubin, R; Miravitlles, M; Ros, F; Tillotson, G	1

Reviews

7 review(s) available for moxifloxacin and Acute Disease

Article	Year
Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis. JAMA network open, 2022, 10-03, Volume: 5, Issue:10 Topics: Acute Disease; Anti-Bacterial Agents; Child; Child, Preschool; Conjunctivitis; Female; Humans; Male; Moxifloxacin; Ophthalmic Solutions; Randomized Controlled Trials as Topic	2022
Postoperative Mycoplasma hominis infections after neurosurgical intervention. Journal of neurosurgery. Pediatrics, 2014, Volume: 14, Issue:2 Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Cervical Vertebrae; Delayed Diagnosis; Empyema, Subdural; Epidural Abscess; Fluoroquinolones; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Male; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Neurosurgical Procedures; Postoperative Complications; Spinal Cord Compression; Spinal Injuries; Surgical Wound Dehiscence; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome	2014
[15-year experience of moxifloxacin in the treatment of patients with bacterial rhinosinusitis]. Vestnik otorinolaringologii, 2015, Volume: 80, Issue:3 Topics: Acute Disease; Anti-Bacterial Agents; Bacterial Infections; Fluoroquinolones; Humans; Moxifloxacin; Rhinitis; Russia; Sinusitis; Treatment Outcome	2015
The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis. Expert review of respiratory medicine, 2012, Volume: 6, Issue:5 Topics: Acute Disease; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Bronchitis; Chronic Disease; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines	2012
Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: a pooled analysis. Clinical therapeutics, 2004, Volume: 26, Issue:2 Topics: Acute Disease; Adult; Aza Compounds; Drug Tolerance; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillin Resistance; Pneumococcal Infections; Quinolines; Severity of Illness Index; Sinusitis; Streptococcus pneumoniae	2004
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. Respiratory medicine, 2006, Volume: 100, Issue:10 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome	2006
Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Mar-25, Volume: 178, Issue:7 Topics: Acute Disease; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Fluoroquinolones; Humans; Moxifloxacin; Pneumococcal Infections; Quinolines; Randomized Controlled Trials as Topic; Sinusitis	2008

Trials

19 trial(s) available for moxifloxacin and Acute Disease

Article	Year
Effect of Oral Moxifloxacin vs Intravenous Ertapenem Plus Oral Levofloxacin for Treatment of Uncomplicated Acute Appendicitis: The APPAC II Randomized Clinical Trial. JAMA, 2021, 01-26, Volume: 325, Issue:4 Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Moxifloxacin; Tomography, X-Ray Computed; Young Adult	2021
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial. Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Corneal Endothelial Cell Loss; Endophthalmitis; Female; Humans; Incidence; Injections; Intraocular Pressure; Male; Middle Aged; Moxifloxacin; Phacoemulsification; Prospective Studies; Visual Acuity	2019
Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study. PloS one, 2013, Volume: 8, Issue:4 Topics: Activities of Daily Living; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Aza Compounds; Child; Child, Preschool; Europe; Female; Fluoroquinolones; Humans; Infant; Male; Middle Aged; Middle East; Moxifloxacin; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Sleep; Treatment Outcome	2013
Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin. International journal of clinical practice, 2008, Volume: 62, Issue:9 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome; Young Adult	2008
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. International journal of STD & AIDS, 2009, Volume: 20, Issue:10 Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Double-Blind Method; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Pelvic Inflammatory Disease; Quinolines; Treatment Outcome	2009
Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. Respiratory medicine, 2012, Volume: 106, Issue:9 Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Forced Expiratory Volume; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolines; Recovery of Function; Risk Factors; Treatment Outcome	2012
Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI). BMC pulmonary medicine, 2013, Jan-23, Volume: 13 Topics: Activities of Daily Living; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prevalence; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinolines; Risk Factors; Sleep Wake Disorders	2013
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis, Chronic; Ceftriaxone; Costs and Cost Analysis; Female; Fluoroquinolones; Humans; Italy; Male; Middle Aged; Moxifloxacin; National Health Programs; Quinolines; Time Factors; Treatment Outcome	2002
Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults. The Journal of laryngology and otology, 2003, Volume: 117, Issue:1 Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Naphthyridines; Prospective Studies; Quinolines; Treatment Outcome	2003
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest, 2004, Volume: 125, Issue:3 Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines	2004
Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004, Volume: 131, Issue:3 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aza Compounds; Bacterial Infections; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Ketolides; Macrolides; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Rhinitis; Sinusitis; Time Factors	2004
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Respiratory medicine, 2005, Volume: 99, Issue:8 Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Drug Therapy, Combination; Epidemiologic Methods; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Oxygen Inhalation Therapy; Prognosis; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome	2005
Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group. Clinical therapeutics, 1999, Volume: 21, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines	1999
Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:4 Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Bronchitis; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines	1999
Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Respiratory medicine, 2000, Volume: 94, Issue:1 Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Treatment Outcome	2000
A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respiratory medicine, 2000, Volume: 94, Issue:4 Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Cefuroxime; Cephalosporins; Double-Blind Method; Drug Evaluation; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Sinusitis	2000
The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis. Respiratory medicine, 2000, Volume: 94, Issue:11 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Prospective Studies; Quinolines	2000
Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. International journal of clinical practice, 2001, Volume: 55, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome	2001
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience. International journal of clinical practice, 2001, Volume: 55, Issue:7 Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Bronchitis; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Treatment Outcome	2001

Other Studies

27 other study(ies) available for moxifloxacin and Acute Disease

Article	Year
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11 Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological Availability; Chronic Disease; DNA Gyrase; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Macrophages; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Piperidines; Protein Subunits; Rats; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis, Pulmonary	2014
Bilateral acute anterior uveitis and iris atrophy caused by moxifloxacin. BMJ case reports, 2020, Jun-30, Volume: 13, Issue:6 Topics: Acute Disease; Anti-Bacterial Agents; Atrophy; Humans; Iris; Male; Middle Aged; Moxifloxacin; Mydriasis; Pneumonia; Tomography, Optical Coherence; Treatment Outcome; Uveitis, Anterior	2020
Evolving Issues in the Use of Antibiotics for the Treatment of Uncomplicated Appendicitis. JAMA, 2021, 01-26, Volume: 325, Issue:4 Topics: Acute Disease; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ertapenem; Humans; Levofloxacin; Moxifloxacin	2021
[Moxiflaxin and iris transillumination]. Revue medicale de Liege, 2016, Volume: 71, Issue:7-8 Topics: Acute Disease; Adult; Bronchitis; Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Moxifloxacin; Pigment Epithelium of Eye	2016
Is oral moxifloxacin associated with bilateral acute iris transillumination? Acta ophthalmologica, 2018, Volume: 96, Issue:4 Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Male; Middle Aged; Moxifloxacin	2018
Bilateral acute iris transillumination syndrome. A case report. Archivos de la Sociedad Espanola de Oftalmologia, 2018, Volume: 93, Issue:9 Topics: Acute Disease; Anti-Bacterial Agents; Diagnostic Errors; Female; Glaucoma, Open-Angle; Humans; Iris; Middle Aged; Moxifloxacin; Mydriasis; Respiratory Tract Infections; Syndrome; Uveitis, Anterior	2018
Acute pelvic inflammatory disease as a rare cause of acute small bowel obstruction. Acta chirurgica Belgica, 2019, Volume: 119, Issue:5 Topics: Abdomen, Acute; Acute Disease; Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Female; Humans; Intestinal Obstruction; Intestine, Small; Laparoscopy; Metronidazole; Moxifloxacin; Pelvic Inflammatory Disease; Tomography, X-Ray Computed	2019
Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin. Journal of cataract and refractive surgery, 2018, Volume: 44, Issue:12 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Combinations; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Phacoemulsification; Retrospective Studies; Surgical Wound Infection; Triamcinolone	2018
Acute iris depigmentation following systemic moxifloxacin. Clinics (Sao Paulo, Brazil), 2013, Volume: 68, Issue:7 Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Iris Diseases; Male; Moxifloxacin; Pigmentation Disorders; Quinolines	2013
Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study. Pharmacotherapy, 2014, Volume: 34, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Fluoroquinolones; Humans; Incidence; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Risk	2014
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome. Ophthalmology, 2016, Volume: 123, Issue:8 Topics: Acute Disease; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cyclosporine; Dexamethasone; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorophotometry; Fluoroquinolones; Glucocorticoids; Guidelines as Topic; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Tobramycin; Visual Acuity	2016
In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis. World journal of gastroenterology, 2008, May-28, Volume: 14, Issue:20 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bile; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus; Escherichia coli; Female; Fluoroquinolones; Humans; Klebsiella; Male; Middle Aged; Moxifloxacin; Piperacillin; Prospective Studies; Quinolines; Sulbactam	2008
[Fatal acute hepatitis and cholestasis associated with liver disease]. Medicina clinica, 2010, Mar-20, Volume: 134, Issue:8 Topics: Acute Disease; Anti-Infective Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Cholestasis; Fatal Outcome; Fluoroquinolones; Humans; Liver Diseases, Alcoholic; Male; Middle Aged; Moxifloxacin; Quinolines	2010
Biopsy proven acute interstitial nephritis after treatment with moxifloxacin. BMC nephrology, 2010, Aug-23, Volume: 11 Topics: Acute Disease; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aza Compounds; Biopsy; Carcinoma, Non-Small-Cell Lung; Creatinine; Edema; Eosinophilia; Fluoroquinolones; Humans; Lung Neoplasms; Male; Moxifloxacin; Nephritis, Interstitial; Pneumonectomy; Pneumonia; Postoperative Complications; Prednisolone; Quinolines	2010
Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery. Acta ophthalmologica, 2012, Volume: 90, Issue:7 Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Bacteria; Cataract Extraction; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body	2012
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2012, Oct-02, Volume: 184, Issue:14 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Case-Control Studies; Chemical and Drug Induced Liver Injury; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines	2012
Moxifloxacin-induced acute liver injury. The American journal of gastroenterology, 2002, Volume: 97, Issue:7 Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines	2002
[Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis]. Vestnik otorinolaringologii, 2002, Issue:5 Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Frontal Sinusitis; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Quinolines; Sinusitis; Suppuration; Time Factors	2002
[Acute exacerbated chronic bronchitis. Antibiotics in comparison]. MMW Fortschritte der Medizin, 2003, Oct-02, Volume: 145, Issue:40 Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Smoking; Time Factors	2003
No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest, 2004, Volume: 125, Issue:3 Topics: Acute Disease; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clinical Trials as Topic; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quinolines	2004
[Acute and bilateral uveitis secondary to moxifloxacin]. Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:7 Topics: Acute Disease; Aged; Aza Compounds; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Uveitis	2004
MOSAIC acronym. Chest, 2004, Volume: 126, Issue:5 Topics: Acute Disease; Administration, Oral; Aza Compounds; Bronchitis; Chronic Disease; Double-Blind Method; Fluoroquinolones; Moxifloxacin; Multicenter Studies as Topic; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Tablets; Terminology as Topic	2004
Acute interstitial nephritis associated with moxifloxacin use. Clinical therapeutics, 2005, Volume: 27, Issue:8 Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Aza Compounds; Female; Fluoroquinolones; Humans; Moxifloxacin; Nephritis, Interstitial; Quinolines	2005
Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. Current medical research and opinion, 2006, Volume: 22, Issue:2 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aza Compounds; Database Management Systems; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies; Sinusitis; Treatment Outcome; United States	2006
The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2006, Volume: 10, Issue:5 Topics: Acute Disease; Animals; Anti-Bacterial Agents; Aza Compounds; Azithromycin; CD11b Antigen; CD4 Antigens; CD8 Antigens; Disease Models, Animal; Female; Fluoroquinolones; Male; Mice; Mice, Inbred C57BL; Moxifloxacin; Pneumococcal Infections; Quinolines; Rhinitis; Sinusitis; Streptococcus pneumoniae	2006
Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. American journal of ophthalmology, 2006, Volume: 142, Issue:5 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; Cataract Extraction; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies	2006
[Avelox efficacy in the treatment of acute purulent rhinosinusitis]. Terapevticheskii arkhiv, 2007, Volume: 79, Issue:8 Topics: Acute Disease; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Moxifloxacin; Quinolines; Rhinitis; Suppuration; Tomography, X-Ray Computed; Treatment Outcome	2007